Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
Clinical trial NCT02730351 · COMPLETED
Trial details
- NCT number
- NCT02730351
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-25
- Primary completion
- 2017-02-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.